{
    "clinical_study": {
        "@rank": "122566", 
        "arm_group": {
            "arm_group_label": "Veriset\u2122 Hemostatic Patch", 
            "arm_group_type": "Experimental", 
            "description": "Topical hemostat"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to determine the safety of Veriset\u2122 Hemostatic Patch when\n      used during non-emergent, open, soft tissue surgery where a topical hemostatic agent would\n      be used."
        }, 
        "brief_title": "A Prospective, Multi-Center, Single-Arm Study of the Veriset\u2122 Hemostatic Patch in Controlling Bleeding in Soft Tissue", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Subjects received the topical hemostat Veriset\u2122 Hemostatic Patch", 
                        "title": "Veriset\u2122 Hemostatic Patch"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "30"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "12.3", 
                                            "@value": "60.8"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "10"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "20"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Hispanic or Latino"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "30"
                                            }
                                        }, 
                                        "sub_title": "Not Hispanic or Latino"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Unknown or Not Reported"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Ethnicity (NIH/OMB)", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "American Indian or Alaska Native"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Asian"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Native Hawaiian or Other Pacific Islander"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Black or African American"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "30"
                                            }
                                        }, 
                                        "sub_title": "White"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "More than one race"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "Unknown or Not Reported"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Race (NIH/OMB)", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "7.6", 
                                            "@value": "174.0"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Height", 
                            "units": "centimeters"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "19.0", 
                                            "@value": "75.0"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Weight", 
                            "units": "kilograms"
                        }
                    ]
                }, 
                "population": "Baseline demographic and clinical characteristics are summarized by descriptive statistics for continuous variables, and frequencies and percentages for categorical variables. These analyses were performed on the Treated Population."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": "O1"
                                }, 
                                "groups_desc": "The primary effectiveness endpoint was the percent (%) success in obtaining hemostasis at the Target Bleeding Site (TBS) within 5 minutes following Veriset\u2122 application.  An exact (Clopper\u2013Pearson) 95% confidence interval for the true success percentage was calculated. Subjects who received rescue therapy on the target bleeding site prior to obtaining hemostasis were considered failures.", 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "<0.0001", 
                                "p_value_desc": "The p-value from a one-sided exact test was based on the binomial distribution, testing that the true percent success rate was \u2264 50% versus the alternative hypothesis that the success rate was > 50%."
                            }
                        }, 
                        "description": "Success will be defined as hemostasis obtained within 5 minutes.  Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Subjects received the topical hemostat Veriset\u2122 Hemostatic Patch", 
                                "title": "Veriset\u2122 Hemostatic Patch"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "30"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "29"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Success will be defined as hemostasis obtained within 5 minutes.  Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                                    "param": "Number", 
                                    "title": "Percent Success in Obtaining Hemostasis Following Veriset Hemostatic Patch Treatment", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Intra-operative (Day 0)", 
                        "title": "Percent Success in Obtaining Hemostasis Following Veriset Hemostatic Patch Treatment", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": "O1"
                                }, 
                                "groups_desc": "The number and percentage of subjects who achieved hemostasis within 1 minute were presented. An exact (Clopper\u2013Pearson) 95% confidence interval for the true percentage was calculated.", 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "0.0214", 
                                "p_value_desc": "The p-value from a one-sided exact test was based on the binomial distribution, testing that the true percent success rate was \u2264 50% versus the alternative hypothesis that the success rate was > 50%."
                            }
                        }, 
                        "description": "Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Subjects received the topical hemostat Veriset\u2122 Hemostatic Patch", 
                                "title": "Veriset\u2122 Hemostatic Patch"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "30"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "50.6", 
                                                    "@upper_limit": "85.3", 
                                                    "@value": "21"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                                    "param": "Number", 
                                    "title": "Proportion of Subjects Who Achieve Hemostasis Within 1 Minute", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Intra-operative (Day 0)", 
                        "title": "Proportion of Subjects Who Achieve Hemostasis Within 1 Minute", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_n_sides": "1-Sided", 
                                "ci_percent": "95", 
                                "ci_upper_limit": "1.0", 
                                "group_id_list": {
                                    "group_id": "O1"
                                }, 
                                "groups_desc": "Time to achieve hemostasis was analyzed using the Kaplan\u2013Meier method to estimate the survival distribution and to obtain the estimated median time to hemostasis.  Additionally, A 95% Brookmeyer\u2013Crowley confidence interval for the median was computed based on the sign test.", 
                                "non_inferiority": "No", 
                                "param_type": "Median Difference (Final Values)", 
                                "param_value": "1.0"
                            }
                        }, 
                        "description": "Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Subjects received the topical hemostat Veriset\u2122 Hemostatic Patch", 
                                "title": "Veriset\u2122 Hemostatic Patch"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "30"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "0.5", 
                                                    "@upper_limit": "1.0", 
                                                    "@value": "1"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Median", 
                                    "title": "Median Time to Achieve Hemostasis", 
                                    "units": "Minutes"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Intra-operative (Day 0)", 
                        "title": "Median Time to Achieve Hemostasis", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Subjects received the topical hemostat Veriset\u2122 Hemostatic Patch", 
                        "title": "Veriset\u2122 Hemostatic Patch"
                    }
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Lost to Follow-up"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "Death"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "30", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "28", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "2", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "Subjects who met the pre-operative eligibility criteria were considered for study participation. During the surgical procedures, subjects who met the intra-operative eligibility criteria were enrolled into the study.  Subjects who did not meet all criteria were considered screen failures and not enrolled.", 
                "recruitment_details": "Subjects who were scheduled for non-emergent, soft tissue procedures performed via an open approach were assessed for potential study eligibility via a screening/baseline assessment performed within 30 days of their scheduled procedure."
            }, 
            "point_of_contact": {
                "email": "Julie.Totten@Covidien.com", 
                "name_or_title": "Julie Totten", 
                "organization": "Covidien", 
                "phone": "781-839-1729"
            }, 
            "reported_events": {
                "desc": "All adverse events were reported, regardless of relationship to study device.", 
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Subjects received the topical hemostat Veriset\u2122 Hemostatic Patch", 
                        "title": "Veriset\u2122 Hemostatic Patch"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "17", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Anaemia"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Duodenitis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Dyspepsia"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Vomiting"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Impaired healing"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Seroma"
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Hepatic enzyme increased"
                                    }
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Fluid retention"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Hypokalaemia"
                                        }
                                    ]
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Renal impairment"
                                    }
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Pleural effusion"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Respiratory failure"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Haematoma"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Hypertension"
                                        }
                                    ]
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "MedDRA (14.1)", 
                    "frequency_threshold": "5"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "11", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Atrial fibrillation"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Sick sinus syndrome"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Tachyarrhythmia"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Abdominal wall haemorrhage"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Mesenteric haemorrhage"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Impaired healing"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Hepatic failure"
                                    }
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Bacterial diarrhoea"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Gastroenteritis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Neutropenic sepsis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Sepsis"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Anastomotic complication"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Gastrointestinal anastomotic leak"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            "sub_title": "Post procedural haemorrhage"
                                        }
                                    ]
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Laboratory test abnormal"
                                    }
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Neoplasm progression"
                                    }
                                }, 
                                "title": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Adjustment disorder with depressed mood"
                                    }
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Renal failure"
                                    }
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Respiratory distress"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "30"
                                        }, 
                                        "sub_title": "Haemorrhage"
                                    }
                                }, 
                                "title": "Vascular disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "MedDRA (14.1)"
                }, 
                "time_frame": "Adverse events were collected through the 90 day follow-up visit."
            }
        }, 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Non-emergent, Soft Tissue Procedures, Performed Via an Open Approach", 
        "condition_browse": {
            "mesh_term": "Hemorrhage"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject or authorized representative has provided informed consent.\n\n          -  Subject is \u2265 18 years old.\n\n          -  Subject is scheduled for nonemergent surgery where a topical hemostatic agent would\n             be used to control bleeding emanating from a tissue bed following organ dissection or\n             removal or a bleeding tumor tissue bed following resection or dissection, via an open\n             approach.\n\n          -  Subject is willing and able to comply with all aspects of the treatment and\n             evaluation schedule.\n\n          -  Subject has an appropriate Target Bleeding Site (TBS) during the surgical procedure.\n\n          -  TBS bleeding assessment is Type 2 or 3 (refer to table in protocol).\n\n        Exclusion Criteria:\n\n          -  Subject is pregnant (documented by a positive pregnancy test) or is actively\n             breast-feeding.\n\n          -  Subject has an estimated life expectancy of less than 6 months.\n\n          -  Subject is scheduled for another planned surgery and the subsequent surgery would\n             jeopardize the previous application of study treatment.\n\n          -  Subject is undergoing emergency surgery, i.e. lifesaving procedures performed where\n             patient is in imminent danger of death.\n\n          -  Subject has participated in an investigational drug or device research study within\n             30 days of enrollment that would interfere with the study.\n\n          -  Subject has an active local infection at the TBS.\n\n          -  The investigator determines that participation in the study may jeopardize teh safety\n             or welfare of the subject."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 30, 2012", 
        "firstreceived_results_date": "January 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01719172", 
            "org_study_id": "COVEUST0278"
        }, 
        "intervention": {
            "arm_group_label": "Veriset\u2122 Hemostatic Patch", 
            "description": "Topical Hemostat", 
            "intervention_name": "Veriset\u2122 Hemostatic Patch", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": "Hemostatics"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 17, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Innsbruck", 
                        "country": "Austria"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Germany"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Multi-Center, Single-Arm Study of the Veriset\u2122 Hemostatic Patch in Controlling Bleeding in Soft Tissue", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Austria: Ethikkommission", 
                "Germany: Ethics Commission"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Success will be defined as hemostasis obtained within 5 minutes.  Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
            "measure": "Percent Success in Obtaining Hemostasis Following Veriset Hemostatic Patch Treatment", 
            "safety_issue": "No", 
            "time_frame": "Intra-operative (Day 0)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01719172"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                "measure": "Proportion of Subjects Who Achieve Hemostasis Within 1 Minute", 
                "safety_issue": "No", 
                "time_frame": "Intra-operative (Day 0)"
            }, 
            {
                "description": "Hemostasis will be assessed every 30 seconds until the 5-minute time point, at which point the visual inspection will continue at one-minute intervals up to 10 minutes or until hemostasis is achieved.", 
                "measure": "Median Time to Achieve Hemostasis", 
                "safety_issue": "No", 
                "time_frame": "Intra-operative (Day 0)"
            }
        ], 
        "source": "Covidien", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Covidien", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}